Fluzone High-dose Quadrivalent Northern Hemisphere Injection, Suspension
Product Images NDC 49281-226

This is a description of the Fluzone® High-Dose Beony Quadrivalent Influenza Vaccine. The vaccine is intended for individuals who are 65 years of age and older and is administered via injection. The specific lot number and expiration date are not provided in the given text. The vaccine is manufactured by Sanofi Pasteur Inc. and uses the 2022-2023 formula.*

This text contains a mixture of readable characters and non-readable characters that appear to be the result of errors during the process. The readable text includes a reference to an intramuscular injection for an influenza vaccine called Fluzone High-Dose Quadrivalent, manufactured by Sanofi Pasteur Inc. The vaccine comes in pre-filled syringes and is indicated for individuals over the age of 65. There is also a reference to a formula and NDC number for the 2022-2023 flu season. The bottom area contains a space reserved for Lot, Expiry, SN & GTIN.*

This is a description of the Fluzone High-Dose Quadrivalent influenza vaccine. It is for intramuscular injection only and should not be frozen. The vaccine contains influenza viruses propagated in embryoated chickens and inactivated with formaldehyde. It is standardized according to USPHS requirements and formulated to contain 3.3-4.8 micrograms (μg) hemagglutinin (HA) per 0.7 mL dose, recommended for the 2022-2023 influenza season. The vaccine contains four prototype strains, including two influenza A strains and two influenza B strains. The vaccine is preservative-free and does not contain natural rubber latex. The vaccine is packaged in single-dose prefilled syringes. More information can be found in the full prescribing information.*